drugset

Drugs / ACP-01

Follow last change Dec 2025 re-read 3 minutes ago

ACP-01

Developed for: limb ischemia

Trials 0

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Comparator or background therapy1 trial
Phase 2	NCT02551679 Comparator	Aug 2014 → Apr 2020	limb ischemia	Hemostemix	Completed	No outcome recorded

Press releases naming this drug 14 releases

Date	Issuer	Release
2025-12-18	Hemostemix	Hemostemix Launches Enhanced HubSpot-Powered Websites to Support Global Marketing & Sales of ACP-01 for No-Option Patients hemostemix.com ↗
2025-12-18	Hemostemix	Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia hemostemix.com ↗
2025-11-13	Hemostemix	Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds hemostemix.com ↗
2025-09-23	Hemostemix	Hemostemix Files FDA Submission for Basket Protocol (Filing 1517) to Advance ACP-01 (VesCell™) Across Multiple Ischemic and Vascular Indications Simultaneously hemostemix.com ↗
2025-08-28	Hemostemix	Hemostemix’s Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial hemostemix.com ↗
2025-08-28	Hemostemix	Hemostemix Thanks Niem Malo, Beefstro’s Founder, for his ACP-01 Testimonial Interview hemostemix.com ↗
2025-08-28	Hemostemix	Hemostemix Sells its 23rd ACP-01 Therapy Convertible Debenture hemostemix.com ↗
2025-08-28	Hemostemix	Hemostemix Offers up to 500 6% Convertible Debentures, Convertible into an ACP-01 Therapeutic Production Slot that is Subject to Compassionate Exemption from Regulatory Approval hemostemix.com ↗
2025-08-28	Hemostemix	HEMOSTEMIX CLOSES SALE OF 23RD ACP-01 THERAPY CONVERTIBLE DEBENTURE hemostemix.com ↗
2025-08-28	Hemostemix	Hemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01 hemostemix.com ↗
2025-08-28	Hemostemix	Hemostemix Announces First Sales Orders for ACP-01 hemostemix.com ↗
2025-08-28	Hemostemix	HEMOSTEMIX ANNOUNCES ACP-01 TREATMENT-PURCHASE AVAILABLE WITH SOCIAL MEDIA CAMPAIGN UNDERWAY hemostemix.com ↗
2025-08-28	Hemostemix	Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA™) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01 hemostemix.com ↗
2025-08-28	Hemostemix	Cells: Hemostemix ACP-01 and NCP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants hemostemix.com ↗

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	ACP-01	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02551679 ↗
Modality	Cell therapy	“Blood-Derived Autologous Angiogenic Cell Precursor Therapy” NCT02551679 ↗
Route	Intramuscular	“autologous ACPs administered intramuscularly” NCT02551679 ↗